Publications for Wilbert S. Aronow wilbert_aronow@nymc.edu

NYMC School of Medicine
  • Liu, Y., Carrey, Z., Aronow, W. S., Alaie, D., Petrillo, R. L., & Frishman, W. H. (2015). The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in postangioplasty restenosis. American Journal of Therapeutics, 22(4), e107-e114. doi:10.1097/MJT.0b013e3182979b59

  • Lo, I. J., Aronow, W. S., Tantchou, I. I., Lafaro, R., Marav, A., Muslim, A., & Pothula, S. (2015). Non-typhoidal Salmonella abscess in a patient with a large thymoma: A rare presentation and review of the literature. Archives of Medical Science, 11(2), 453-457. doi:10.5114/aoms.2015.50979

  • Mujib, M., Aronow, W. S., Kolte, D., Khera, S., Palaniswamy, C., Jain, D., Lanier, G. M., Sule, S., Cooper, H. A., Panza, J. A., . . . Gass, A. L.  (2015). Pretransplant coagulopathy and in-hospital outcomes among heart transplant recipients: A propensity-matched nationwide inpatient sample study. Clinical Cardiology, 38(5), 300-308. doi:10.1002/clc.22391

  • Nairooz, R., Sardar, P., & Aronow, W. S. (2015). Not all NSTEMIs are created equal. Journal of the American College of Cardiology, 65(16), 1718. doi:10.1016/j.jacc.2015.01.053

  • Nairooz, R., Sardar, P., Payne, J., Aronow, W. S., & Paydak, H. (2015). Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation. International Journal of Cardiology, 187, 426-429. doi:10.1016/j.ijcard.2015.03.376

  • Nairooz, R., Sardar, P., Pino, M., Aronow, W. S., Sewani, A., Mukherjee, D., . . . Maskoun, W. (2015). Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation. International Journal of Cardiology, 187, 345-353. doi:10.1016/j.ijcard.2015.03.323

  • Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., . . . American Heart Association, American College of Cardiology, and American Society of Hypertension (2015). Treatment of hypertension in patients with coronary artery disease: A scientific statement from the american heart association, american college of cardiology, and american society of hypertension. Hypertension, 65(6), 1372-1407. doi:10.1161/HYP.0000000000000018

  • Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., . . . American Heart Association, American College of Cardiology, and American Society of Hypertension (2015). Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American college of Cardiology, and American Society of Hypertension. Circulation, 131(19), e435-e470. doi:10.1161/CIR.0000000000000207

  • Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., . . .  American Heart Association, American College of Cardiology, and American Society of Hypertension (2015). Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American college of Cardiology, and American Society of Hypertension. Journal of the American Society of Hypertension : JASH, 9(6), 453-498. doi:10.1016/j.jash.2015.03.002

  • Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S. +., Black, H. R., Blumenthal, R. S., . . .  American Heart Association, American College of Cardiology, and American Society of Hypertension (2015). Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American college of Cardiology, and American Society of Hypertension. Journal of the American College of Cardiology, 65(18), 1998-2038. doi:10.1016/j.jacc.2015.02.038

  • Sardar, P., Chatterjee, S., Herzog, E., Pekler, G., Mushiyev, S., Visco, F., . . . Aronow, W. S. (2015). New oral anticoagulants in patients with cancer: Current state of evidence. American Journal of Therapeutics, 22(6), 460-468. doi:10.1097/MJT.0000000000000055

  • Sardar, P., Kundu, A., Nairooz, R., Chatterjee, S., Ledley, G. S., & Aronow, W. S. (2015). Health resource variability in the achievement of optimal performance and clinical outcome in ischemic heart disease. Current Cardiology Reports, 17(2), 1. doi:10.1007/s11886-014-0551-y

  • Sharma, D., Newman, T. G., & Aronow, W. S. (2015). Lung cancer screening: History, current perspectives, and future directions. Archives of Medical Science, 11(5), 1033-1043. doi:10.5114/aoms.2015.54859

  • Tariq, S., & Aronow, W. S. (2015). Use of inotropic agents in treatment of systolic heart failure. International Journal of Molecular Sciences, 16(12), 29060-29068. doi:10.3390/ijms161226147

  • Alagiakrishnan, K., Patel, K., Desai, R. V., Ahmed, M. B., Fonarow, G. C., Forman, D. E., . . . Aronow, W. S. (2014). Orthostatic hypotension and incident heart failure in community-dwelling older adults. Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 69A(2), 223-230. doi:10.1093/gerona/glt086

  • Aronow, W. S. (2014). 2014 update on management of hypertension. Cardiology (Switzerland), 128(Suppl. 1), 347.

  • Aronow, W. S. (2014). Abdominal aortic aneurysm. Journal of Clinical and Experimental Cardiology, 5(9), 1000e137. doi:10.4172/2155-9880.1000e137

  • Aronow, W. S. (2014). Association of lower extremity peripheral arterial disease with atherosclerotic vascular disease, cardiovascular events and mortality. Journal of Cardiovascular Diseases & Diagnosis, 2(1), 1000e105. doi:10.4172/2329-9517.1000e105

  • Aronow, W. S. (2014). Association of systolic blood pressure levels with cardiovascular events and all- cause mortality in older adults taking antihypertensive treatment in the REGARDS study. Heart Health: Open Access, 1(1), 102. http://aperito.org/uploads/pdf/HH0A-1-102.pdf

  • Aronow, W. S. (2014). Editorial commentary on recent guidelines for treating hypertension. Archives of Medical Science : AMS, 10(6), 1069-1072. doi:10.5114/aoms.2014.47818

  • Aronow, W. S. (2014). Eighth Joint National Committee guidelines. Future Cardiology, 10(4), 461-463. doi:10.2217/fca.14.27

  • Aronow, W. S. (2014). Indications for implantable cardioverter-defibrillator therapy and recommendations for implantable cardioverter-defibrillator therapy in patients not included or not well represented in clinical trials. Journal of Cardiovascular Diseases & Diagnosis, 2(5), 1000e106. doi:10.4172/2329-9517.1000e106

  • Aronow, W. S. (2014). Lipid disorders in the elderly. In Caplan, M. (Ed.), Reference module in biomedical sciences. Elsevier.

  • Aronow, W. S. (2014). Meta-analysis finds benefit for dual antiplatelet therapy but limitations preclude changing standard mono antiplatelet therapy approach for acute non-cardioembolic ischaemic stroke or transient ischaemic attack. Evidence-Based Medicine, 19(3), 94. doi:10.1136/eb-2013-101649

  • Aronow, W. S. (2014). Recent guidelines for treating hypertension. Annals of Clinical and Experimental Hypertension, 2(2), 1011.

First Prev 2 3 4 5 6 7 8 9 10 11 Next Last